A panel of medical oncologists who specialize in renal cell carcinoma (RCC) introduce themselves and discuss the first-line treatment landscape and risk stratification of clear cell RCC.
Retrospective Data Shed Light on Prognostic Value of PD-L1 Expression in Metastatic Papillary RCC
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
TIBs Linked With Poor Outcomes With Anti–PD-1 Therapy Plus Axitinib in Metastatic ccRCC
Merkow and Connell Highlight Considerations for HAI Pump Use in CRC
OncLive’s April Roundup of Key FDA Decisions in Oncology
Applying the Heterogeneous Approach From NSCLC to SCLC
Dr Pal Previews ASCO 2024 Data in Renal Cell Carcinoma
Prospective Data Reveal Most Young Survivors of Breast Cancer Could Successfully Give Birth
HPV Vaccinations Associated With Lower Rates of HPV-Caused Cancers in Patients Under 40 Years of Age
AI Virtual Navigation May Reengage Patients to Undergo Missed Colonoscopies